Core Scientific, Inc. (CORZ)

Close U.S. stock futures are gaining after the Nasdaq and S&P 500 closed at fresh record highs yesterday following a tame inflation report; CoreWeave (CRWV) shares are down sharply in premarket trading after the Nvidia-backed firm reported a wider-than-expected loss; CAVA Group (CAVA) shares are plummeting after the fast-casual chain's same-restaurant sales came in far lower than expected and it cut its outlook; the International Energy Agency raises its global oil supply projections; and Perplexity reportedly offers to buy Google's Chrome in an unsolicited $34.5 billion bid. Here's what investors need to know today. 1. US Stock Futures Point Higher Following Fresh Records for Nasdaq, S&P 500 U.S. stock futures are rising after the Nasdaq and S&P 500 closed at record highs yesterday as investors reacted to the latest inflation reading. Nasdaq and S&P 500 futures are 0.2% higher, while Dow Jones Industrial Average futures are up by 0.3% after the blue-chip index neared its first record high since December. Bitcoin (BTCUSD) is higher, trading at more than $120,000. The yield on the 10-year Treasury note is pointing lower, while oil futures are declining by 0.7%. Gold futures are slightly higher. 2. CoreWeave Stock Sinks as Nvidia-Backed Firm Reports Wider-Than-Expected Loss CoreWeave (CRWV) shares are lower by 9% in premarket trading after the AI cloud provider reported a wider-than-expected loss. The Nvidia-backed firm reported a net loss of 60 cents per share, while analysts polled by Visible Alpha expected a narrower loss of 45 cents per share. The firm reported revenue of $1.21 billion, above expectations. Last month, CoreWeave reached an agreement to acquire longtime data center partner Core Scientific (CORZ) in an all-stock deal worth roughly $9 billion. Shares of CoreWeave have more than tripled since the firm's March initial public offering. 3. CAVA Group Stock Dives on Disappointing Same-Restaurant Sales Growth, Outlook Cut CAVA Group (CAVA) shares are plummeting nearly 25% in premarket trading after the fast-casual restaurant chain posted disappointing same-restaurant sales growth and cut its full-year outlook. CAVA's same-restaurant sales growth of 2.1% was far below the Visible Alpha consensus of 6.25%, and it cut its full-year outlook for the metric to between 4% and 6% from the prior range of 6% to 8%. CAVA's second-quarter revenue of $278.2 million also came up short of estimates. Shares entered Wednesday down 25% this year. 4. IEA Raises Global Oil Supply Projections The International Energy Agency once again has lifted its forecasts for global oil supply this year and next. The IEA on Wednesday said it now sees global oil supply growth of 2.5 million barrels per day (B/D) this year, up by 370,000 b/d from last month's forecast, and 1.9 million b/d in 2026, up by 620,000 b/d. Meanwhile, "the latest data show lacklustre demand across the major economies and, with consumer confidence still depressed, a sharp rebound appears remote," the IEA wrote. 5. Perplexity Offers to Buy Google's Chrome for $34.5B, Report Says AI startup Perplexity is offering to buy Google's Chrome in an unsolicited $34.5 billion bid, according to a report in The Wall Street Journal. The bid would be larger than Perplexity's estimated value of $18 billion, the report said. The reported offer comes as Google faces uncertainty from an antitrust ruling that could be announced as soon as this week, with a federal judge set to decide what steps Google must take after the company was found to have maintained an illegal monopoly in search. Forcing a sale of Chrome could be part of the decision, something the Department of Justice pushed for last year. Shares of Google parent Alphabet (GOOGL) are edging higher in premarket trading. Do you have a news tip for Investopedia reporters? Please email us at [email protected]

The headline numbers for Core Scientific, Inc. (CORZ) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Core Scientific, Inc. (CORZ) came out with a quarterly loss of $0.04 per share versus the Zacks Consensus Estimate of a loss of $0.07. This compares to a loss of $0.04 per share a year ago.

Core Scientific Revenue Falls 44 Percent

AUSTIN, Texas--(BUSINESS WIRE)--Core Scientific, Inc. (NASDAQ: CORZ), a leader in digital infrastructure for high-density colocation services and digital asset mining, today announced financial results for the fiscal second quarter of 2025. Fiscal Second Quarter 2025 Financial Results Total revenue was $78.6 million compared to $141.1 million in the second quarter of 2024. Digital asset self-mining revenue was $62.4 million, down from $110.7 million in the prior-year period. The decline was pri.

MILWAUKEE--(BUSINESS WIRE)--The Ademi Firm is investigating Core Scientific (NYSE: CORZ) for possible breaches of fiduciary duty and other violations of law in its transaction with CoreWeave. Click here to learn how to join our investigation and obtain additional information or contact us at gademi@ademilaw.com or toll-free: 866-264-3995. There is no cost or obligation to you. In the transaction, shareholders of Core Scientific will receive 0.1235 newly issued shares of CoreWeave Class A common.

Two Seas Capital, the largest shareholder of Core Scientific , issued an open letter on Thursday saying it would vote against the company's proposed sale to CoreWeave.

Issues Open Letter to Core Scientific Shareholders Outlining Its Belief that the Proposed Transaction Materially Undervalues Core Scientific and Unnecessarily Exposes Shareholders to Substantial Economic Risk NEW YORK , Aug. 7, 2025 /PRNewswire/ -- Two Seas Capital LP ("Two Seas" or "we"), an alternative investment management firm and the largest active shareholder of Core Scientific, Inc. ("Core Scientific" or the "Company") (NASDAQ: CORZ), today announced its opposition to the Company's proposed sale to CoreWeave, Inc. ("CoreWeave") (NASDAQ: CRWV) on the terms announced on July 7, 2025. Two Seas also released the following open letter to fellow Core Scientific shareholders explaining why it opposes the transaction.

AUSTIN, Texas--(BUSINESS WIRE)--Core Scientific, Inc. (Nasdaq: CORZ), a leader in digital infrastructure for high-density colocation services and bitcoin mining, today announced it will release its second quarter fiscal year 2025 financial results after financial markets close on Friday, August 8, 2025. Due to the pending transaction with CoreWeave, Inc., which was previously announced on July 7, 2025, the Company will not be hosting a conference call or webcast to discuss its second quarter fi.

CoreWeave (NASDAQ:CRWV)'s $9 billion all-stock acquisition of data center operator Core Scientific (NASDAQ:CORZ) is facing shareholder resistance, with major investors saying they may vote against the deal unless its terms are updated, according to a Financial Times report. The FT, citing people familiar with the matter, said the pushback stems from concerns that the current offer undervalues Core Scientific and exposes its investors to unnecessary downside risk.

CoreWeave's $9 billion deal to buy data centre landlord Core Scientific is facing a potential revolt, with some top shareholders of the target company arguing it could leave them short-changed, the Financial Times reported on Tuesday.

CoreWeave's acquisition of CORZ transforms it into a key AI infrastructure play, locking in power assets and slashing costs for long-term growth. Multi-billion-dollar contracts with OpenAI and Google provide real revenue visibility, shifting CORZ from speculative crypto to high-margin, recurring AI cash flows. Options flow, GEX, and dark pool data all point to bullish institutional sentiment, supporting a structured $15/$20 call spread for risk-defined upside exposure.

MONSEY, N.Y., July 23, 2025 (GLOBE NEWSWIRE) -- The law firm of Wohl & Fruchter LLP is investigating the fairness of the proposed merger of Core Scientific, Inc. (Nasdaq: CORZ) (“Core Scientific”) with CoreWeave, Inc. (“CoreWeave”) in an all-stock transaction under which Core Scientific stockholders will receive 0.1235 newly issued shares of CoreWeave Class A common stock for each share of Core Scientific common stock that they own based on a fixed exchange ratio.

Since the historic institutional pivot of 2020, Bitcoin has steadily made its way from fringe asset to mainstream corporate treasury tool.

CoreWeave's acquisition of Core Scientific aims to verticalize data center ownership and cut $500 million in costs by 2027. The deal gives CoreWeave direct control over data center assets, enabling faster, tailored AI infrastructure deployments and improved cost efficiency. Despite operational benefits, the market reacted negatively, with CoreWeave shares dropping and the deal value for Core Scientific shareholders declining.

NEW YORK, July 09, 2025 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2024 ISS Securities Class Action Services Report. The firm is headquartered at the Empire State Building in New York City and is investigating Core Scientific, Inc. (NASDAQ: CORZ ) related to its sale to CoreWeave, Inc. Upon completion of the proposed transaction, each outstanding share of Core Scientific common stock will be converted into the right to receive 0.1235 shares of CoreWeave Class A common stock. Core Scientific shareholders will own less than 10% of the combined company. Is it a fair deal?